In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Dirk Sibbing
Speaker
Dirk Sibbing
Dirk Sibbing Dirk Sibbing

Ludwig-Maximilians University, Munich (Germany)

Speciality : Interventional Cardiology

Write your professional biography here ...

14 presentations from this speaker

2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes - Live.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes - Live
  • Speaker : H Thiele (Leipzig,DE), CE Mueller (Basel,CH), M Gilard (Brest Cedex,FR), D Sibbing (Eichenau,DE), J Mehilli (Munich,DE), M Roffi (Geneva,CH), S Windecker (Bern,CH)

Acute and chronic pharmacological treatment of NSTE-ACS.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes
  • Speaker : D Sibbing (Eichenau,DE)

Antithrombotic therapy.

Event : ESC Congress 2018

  • Session : 2018 ESC/EACTS Guidelines on Myocardial Revascularisation
  • Speaker : D Sibbing (Eichenau,DE)

A case of immediate full revascularisation

Event : ESC Congress 2017

  • Session : How to individualise management of STEMI in patients with multivessel disease?
  • Speaker : D Sibbing (Eichenau,DE)

Future direction for research in Clopidrogel's use in day to day clinical practice.

Event : ESC Congress 2016

  • Session : Still learning of DAPT: Clopidogrel out of the game?
  • Speaker : D Sibbing (Eichenau,DE)

How to individualise the choice of how long to maintain dual antiplatelet therapy after acute coronary syndrome

Event : ESC Congress 2016

  • Session : Personalised antiplatelet therapy
  • Speaker : D Sibbing (Eichenau,DE)

High on treatment platelet reactivity – Clinical implications.

Event : ESC Congress 2015

  • Session : Ongoing challenges in ADP receptor blocker therapy
  • Speaker : D Sibbing (Eichenau,DE)

Testing platelet reactivity in patients undergoing PCI to predict bleeding: for whom?

Event : Acute Cardiovascular Care 2015

  • Session : Is there a role for platelet reactivity testing in patients with CAD treated with P2Y12 inhibitors?
  • Speaker : D Sibbing (Eichenau,DE)

Clinical relevance of platelet reactivity and genotype.

Event : ESC Congress 2014

  • Session : Antiplatelet treatment in stable coronary artery disease patients
  • Speaker : D Sibbing (Eichenau,DE)

Innovative ways of de-escalating antiplatelet treatment in ACS patients: TROPICAL-ACS and beyond.

Event : ESC Congress 2014

  • Session : How to use biomarkers to optimize diagnosis, prognosis and treatment of acute coronary syndrome
  • Speaker : D Sibbing (Eichenau,DE)
  • Sponsored by Roche Diagnostics

Management of anti-platelet therapy using multiple electrode aggregometry: study results and future options.

Event : ESC Congress 2013

  • Session : Monitoring of platelet function in PCI patients in clinical routine
  • Speaker : D Sibbing (Eichenau,DE)
  • Sponsored by Roche Diagnostics

Prasugrel.

Event : ESC Congress 2013

  • Session : Underutilisation of novel antiplatelet agents. What went wrong?
  • Speaker : D Sibbing (Eichenau,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are